Skip to main content
. 2012 Mar 5;2(3):e29. doi: 10.1038/nutd.2012.1

Figure 3.

Figure 3

(a) Systemic role of TGF-β/Smad3 signaling in the pathogenesis of type 2 diabetes. (b) Amelioration of type 2 diabetes upon blockade of TGF-β/Smad3 signaling.

HHS Vulnerability Disclosure